-

Ardent Announces Successful Amendment and Extension of Term Loan Facility

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it has successfully amended and extended its $777.5 million Term Loan Facility. The new terms reduce the applicable interest rate by 50 basis points from Term Secured Overnight Financing Rate (SOFR) plus 2.75% to Term SOFR plus 2.25%. The transaction extends the maturity of the facility to September 2032.

“This transaction enhances our financial flexibility and strengthens our capital position, allowing Ardent to continue investing in our communities while pursuing strategic growth,” said Ardent Health Chief Financial Officer Alfred Lumsdaine. “We appreciate the support of our lending partners and their continued confidence in our leadership and long-term growth strategy.”

The amended credit agreement is expected to reduce Ardent’s interest expense by approximately $3.9 million annually.

About Ardent Health

Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 employed and affiliated providers across six states. For more information, please visit ardenthealth.com.

Contacts

Investor Contact:
Dave Styblo, CFA
SVP, Investor Relations
Ardent Health
Investor.Relations@ardenthealth.com
(615) 296-3016

Media Contact:
Rebecca Kirkham
SVP, Communications & Corporate Affairs
Ardent Health
rebecca.kirkham@ardenthealth.com
(615) 296-3000

Ardent Health

NYSE:ARDT

Release Versions

Contacts

Investor Contact:
Dave Styblo, CFA
SVP, Investor Relations
Ardent Health
Investor.Relations@ardenthealth.com
(615) 296-3016

Media Contact:
Rebecca Kirkham
SVP, Communications & Corporate Affairs
Ardent Health
rebecca.kirkham@ardenthealth.com
(615) 296-3000

More News From Ardent Health

Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine

BRENTWOOD, Tenn. & TYLER, Texas--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today marked a milestone in its East Texas partnership as UT Health East Texas expanded specialty care into the new UT Tyler School of Medicine Building in Tyler – the first time patient services and physician training share a single hub in the region. The building now houses UT Health East Texas women's health, pulmonary, orthope...

Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that the Company will participate in the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026, in Boston, Massachusetts. Members of the management team will participate in a fireside chat on September 9, 2026, at 11 a.m. ET. A live audio webcast of the event will be available in the Investor Relations sec...

Oklahoma Heart Institute Brings New National Cardiovascular Trials and Technologies to Patients Across the Region

BRENTWOOD, Tenn. & TULSA, Okla.--(BUSINESS WIRE)--Oklahoma Heart Institute (OHI), part of Hillcrest HealthCare System and Ardent Health (NYSE: ARDT), is now the only site in Oklahoma and the surrounding region participating in several leading national cardiovascular trials – and recently became the first in the United States to use the next-generation Supira percutaneous left ventricular assist device (pVAD) as part of the SUPPORT II clinical trial. Through this research, OHI is expanding acces...
Back to Newsroom